Plant-derived compounds in clinical trials.

Full Abstract

Plants remain an important source of new drugs, new drug leads and new chemical entities. The plant-based drug discovery resulted mainly in the development of anticancer and anti-infectious agents and continues to contribute to the new leads in clinical trials. A total of 91 plant-derived compounds in clinical trials as of September 2007 are described in this review. A summary of the plant-based drugs launched during 2000-2006 is given.

Author information

Author/s: Saklani, Arvind (A); Kutty, Samuel K (SK);

Affiliation: Department of Natural Products, National Institute of Pharmaceutical Education and Research, Sector-67, SAS Nagar 160062, Punjab, India. asaklani(-atsign-)nicholaspiramal.co.in

Journal and publication information

Publication Type: Journal Article; Review

Journal: Drug discovery today (Drug Discov Today), published in England. (Language: eng)

Reference: 2008-Feb; vol 13 (issue 3-4) : pp 161-71

Dates: Created 2008/02/15; Completed 2008/06/06;

PMID: 18275914, status: MEDLINE (last retrieval date: 2/18/2009, IMS Date: )

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article
(including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.